EcoDrugPlus

Ensembl ID : YNL069C
Description: -
122 Possible Orthologues:

Title

Ensembl ID : YNL096C
Description: -
91 Possible Orthologues:

Title

Ensembl ID : YNL106C
Description: -
120 Possible Orthologues:

Title

Ensembl ID : YNL134C
Description: -
920 Possible Orthologues:

Title

Ensembl ID : YNL141W
Description: -
89 Possible Orthologues:

Title

Ensembl ID : YNL154C
Description: -
633 Possible Orthologues:

Title

Ensembl ID : YNL178W
Description: -
208 Possible Orthologues:

Title

Ensembl ID : YNL301C
Description: -
114 Possible Orthologues:

Title

Ensembl ID : YNL331C
Description: -
800 Possible Orthologues:

Title

Ensembl ID : YNR019W
Description: -
63 Possible Orthologues:

Title

Ensembl ID : YNR047W
Description: -
185 Possible Orthologues:

Title

Ensembl ID : YOL039W
Description: -
29 Possible Orthologues:

Title

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).